AI-assisted MRI to classify pediatric brain tumors
Part of Brain & nervous system, Cancer clinical trials.
This trial uses artificial intelligence to analyze MRI scans and help doctors identify the type of brain tumor in children. It aims to improve treatment planning by providing a non-invasive way to predict the tumor subtype before surgery.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be under 18 years old.
- You are about to have your first surgery for a suspected brain tumor.
- You need a preoperative brain MRI with specific scan types (T1, contrast T1, T2, FLAIR).
- After surgery, the tumor type must match one of these: glioma, medulloblastoma, ependymoma, AT/RT, germ cell tumor, craniopharyngioma, or choroid plexus tumor.
- You must not have had any prior brain tumor treatment (surgery, radiation, chemo) before this MRI.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses artificial intelligence to analyze MRI scans from people diagnosed with a type of brain tumor called glioma. It aims to better understand the cancer from diagnosis through treatment, which could help guide future care.
This trial uses an AI computer program to predict the molecular features of a primary brain tumor (glioma) by looking at tumor tissue images. Your results could help researchers better match glioma subtypes to more tailored care, using information obtained from the surgery sample.
This study is testing if artificial intelligence (AI) can look at microscope slides of your brain tumor tissue to guess its genetic makeup. It uses data already collected from your routine care, so there is no extra treatment or medicine involved.
This study will see if a special type of MRI scan (called Arterial Spin Labeling) can help doctors determine how aggressive a child's brain tumor is without needing a biopsy. It is for children age 18 or younger who have a new diagnosis of a brain tumor and have not had any prior treatment for it.
This trial tests an AI tool that helps diagnose brain tumors like glioma, brain metastases, and lymphoma using MRI scans. It may allow faster and more accurate diagnosis without needing additional tests.
This study uses artificial intelligence to analyze MRI scans of midline brain tumors (gliomas) to help predict how the disease may progress and improve treatment planning. Researchers are collecting data from multiple hospitals to teach an AI system to better understand these tumors.
Hear when a new Glioma trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.